Gedeon Richter PLC (LUX:CHWGR)

Market Cap	6.24B +26.6%
Revenue (ttm)	2.40B +5.4%
Net Income	594.57M -4.1%
EPS	3.25 -4.0%
Shares Out	n/a
PE Ratio	10.50
Forward PE	7.93
Dividend	1.24 (3.20%)
Ex-Dividend Date	Jun 3, 2025

Volume	n/a
Open	n/a
Previous Close	40.00
Day's Range	n/a
52-Week Range	27.43 - 43.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 30, 2026

About Gedeon Richter

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women’s healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women’s lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as we...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 11,155
• Stock Exchange: Luxembourg Stock Exchange
• Ticker Symbol: CHWGR

Financial Performance

In 2025, Gedeon Richter's revenue was 928.96 billion, an increase of 8.33% compared to the previous year's 857.55 billion. Earnings were 232.34 billion, a decrease of -2.89%.

Financial numbers in HUF